- Home
- ARVN vs BTO Comparison
ARVN vs BTO Comparison
Compare ARVN & BTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ARVN | BTO |
|---|---|---|
| Founded | 2015 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 781.0M | 673.2M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | ARVN | BTO |
|---|---|---|
| Price | $12.24 | $36.13 |
| Analyst Decision | Buy | |
| Analyst Count | 23 | 0 |
| Target Price | ★ $18.14 | N/A |
| AVG Volume (30 Days) | ★ 792.5K | 54.2K |
| Earning Date | 02-10-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.13% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $312,300,000.00 | N/A |
| Revenue This Year | $11.17 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 93.86 | N/A |
| 52 Week Low | $5.90 | $22.95 |
| 52 Week High | $20.38 | $32.81 |
Technical Indicators
Market Signals| Indicator | ARVN | BTO |
|---|---|---|
| Relative Strength Index (RSI) | 53.70 | 54.66 |
| Support Level | $11.88 | $35.17 |
| Resistance Level | $12.79 | $36.49 |
| Average True Range (ATR) | 0.53 | 0.73 |
| MACD | 0.01 | -0.03 |
| Stochastic Oscillator | 68.02 | 63.28 |
Price Performance
Historical ComparisonAbout ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About BTO John Hancock Financial Opportunities Fund
John Hancock Financial Opportunities Fund is the United States based closed-end, diversified management investment company. Its investment objective is to provide a high level of total return consisting of long-term capital appreciation and current income. The company invests in banks, capital markets, Insurance, Mortage Real Estate Investment trust, Health Care REITs, Diversified REITs, Office REITs.